Aethlon Medical - 9 Year Stock Split History | AEMD

Stock split history for Aethlon Medical since 2015. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Aethlon Medical Annual Stock Splits
Aethlon Medical Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Health Maintenance Organizations $0.004B $0.001B
Aethlon Medical, Inc. is a development stage medical device company focused on expanding the applications of our Hemopurifier (R) platform technology, which is designed to rapidly reduce the presence of infectious viruses and other toxins from human blood. In this regard, its core focus is the development of therapeutic devices that treat acute viral conditions, chronic viral diseases and pathogens targeted as potential biological warfare agents. The Hemopurifier(R) combines the established scientific principles of affinity chromatography and hemodialysis as a means to mimic the immune system's response of clearing viruses and toxins from the blood before cell and organ infection can occur. The Hemopurifier(R) cannot cure viral conditions but can prevent virus and toxins from infecting unaffected tissues and cells. The company has completed pre-clinical blood testing of the Hemopurifier(R) to treat HIV and Hepatitis-C, and have completed human safety trials on Hepatitis-C infected patients in India.
Stock Name Country Market Cap PE Ratio
UnitedHealth Group (UNH) United States $452.882B 19.06
Cigna Group (CI) United States $103.254B 14.07
Centene (CNC) United States $40.428B 11.35
Humana (HUM) United States $39.249B 12.52
Molina Healthcare (MOH) United States $21.200B 17.32
Select Medical Holdings (SEM) United States $3.508B 13.73
Joint (JYNT) United States $0.185B 77.25